Alpha 2.0
Login Register
» Articles » PMID: 4853356

Nitroheterocyclic Drugs As Selective Radiosensitizers of Hypoxic Mammalian Cells

Overview
Journal Cancer Chemother Rep
Specialties Oncology
Pharmacology
Date 1974 Jul 1
PMID 4853356
Citations 6
Authors
J D Chapman
A P Reuvers
J Borsa
J S Henderson
R D Migliore
Affiliations
Soon will be listed here.
Citing Articles

Structure-pharmacokinetic relationships for misonidazole analogues in mice.

Workman P, Brown J Cancer Chemother Pharmacol. 1981; 6(1):39-49.

PMID: 7273265 DOI: 10.1007/BF00253009.

Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse.

Labat C, Terrissol M, Martin B, Oustrin J Eur J Drug Metab Pharmacokinet. 1982; 7(1):17-20.

PMID: 7067719 DOI: 10.1007/BF03189538.

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study.

Eyre H, Ohlsen J, Frank J, LoBuglio A, McCracken J, Weatherall T J Neurooncol. 1984; 2(4):325-30.

PMID: 6397578 DOI: 10.1007/BF00178115.

Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.

Koch C, Howell R, Biaglow J Br J Cancer. 1979; 39(3):321-9.

PMID: 465301 PMC: 2009878. DOI: 10.1038/bjc.1979.56.

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.

Brown J, Yu N, Workman P Br J Cancer. 1979; 39(3):310-20.

PMID: 465300 PMC: 2009863. DOI: 10.1038/bjc.1979.55.